| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.0M | +929.4% |
| Cost of Revenue | $9.7M | +1189.0% |
| Gross Profit | $11.3M | +777.9% |
| R&D Expense | $67.0M | -7.1% |
| SG&A Expense | $26.9M | -30.0% |
| Operating Income | -$82.6M | +24.4% |
| Pre-tax Income | -$72.8M | +27.2% |
| Income Tax | $231K | +22.9% |
| Net Income | -$73.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.5M | -77.1% |
| Accounts Receivable | $4.8M | +403.5% |
| Inventory | $5.2M | +2331.1% |
| Current Assets | $216.3M | -21.9% |
| Total Assets | $272.6M | -17.3% |
| Current Liabilities | $24.2M | +5.9% |
| Total Liabilities | $57.9M | +12.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.4M | +11.7% |
| Capital Expenditures | $2.9M | -76.6% |
| Investing Cash Flow | -$39.2M | -136.2% |
| Financing Cash Flow | -$2.0M | -294.2% |
| Free Cash Flow | -$61.2M | +21.8% |
| +27.1% |
| EPS (Basic) | -$0.22 | +29.0% |
| EPS (Diluted) | -$0.22 | +29.0% |
| Stockholders' Equity |
| $214.8M |
| -22.8% |